Thyroid Regulation

Thyroid Regulation

1 Overview

Summary and Quick Facts

  • Suboptimal thyroid function is common and can contribute to troublesome symptoms like weight gain and fatigue. Since thyroid hormones influence the metabolic activity of every cell, less-than-optimal thyroid function can profoundly affect the body and the mind.
  • This protocol reviews thyroid function and regulation. You’ll learn how so-called normal thyroid lab test results don’t necessarily mean your thyroid isn’t contributing to your symptoms. Important aspects of thyroid function aren’t measured on most standard thyroid lab tests.
  • Combining comprehensive thyroid function testing, integrative nutritional and dietary supplement strategies and judicious thyroid hormone replacement under physician guidance can help restore balanced thyroid function.
  • Selenium and iodine are micronutrients that play key roles in thyroid function. Supplementation can help ensure the thyroid has access to adequate levels of these nutrients.

What Does the Thyroid Do?

The thyroid is an organ in the neck responsible for regulating metabolism by controlling the rate of oxygen and calorie conversion to energy. The metabolic rate of every cell in the body is controlled by thyroid hormones, particularly T3. The thyroid produces the hormones T3 and T4 in response to stimulation by thyroid stimulating hormone (TSH), which is produced in the pituitary gland. The thyroid requires iodine and L-tyrosine to synthesize T3 and T4.

Hyperthyroidism is a condition where the thyroid produces too much thyroid hormone, significantly accelerating metabolism. Hypothyroidism is a condition where the thyroid does not produce enough thyroid hormone, significantly slowing metabolism. Both conditions have detrimental effects on the body. Fortunately, thyroid function tests (eg, TSH, T3, and T4) can help identify an underlying thyroid condition as well as help direct proper treatment and improve symptoms.

Nutrients such as iodine and selenium help support thyroid function.

What are Signs and Symptoms of Hyperthyroidism?

  • Sudden weight loss
  • Rapid heartbeat
  • Sweating
  • Nervousness or irritability
  • Extreme hyperthyroidism can cause elevated heart rate and blood pressure, extreme exhaustion, and high fever. This condition sharply increases the risk of stroke and heart attack, and it can be fatal in up to half of all cases.

What are Signs and Symptoms of Hypothyroidism?

  • Fatigue
  • Weakness
  • Sensitivity to cold
  • Constipation
  • Unexplained weight gain
  • Dry skin and hair (and/or hair loss)
  • Muscle cramps
  • Depression
  • If left untreated, hypothyroidism can lead to goiter, cardiovascular disease, and dementia.

What are Conventional Medical Treatments for Thyroid Regulation?

  • Hyperthyroidism:
    • Anti-thyroid drugs, such as methimazole or propylthiouracil, to inhibit the production of T3
    • Radioactive iodine to destroy the overactive thyroid gland
    • Surgical removal of the thyroid
    • Βeta-blockers to control high blood pressure and increased heart rate
  • Hypothyroidism:
    • Thyroid hormone replacement therapy
    • Desiccated thyroid extract

Which Nutrients Support Thyroid Health?

  • Iodine. Iodine is required to synthesize thyroid hormone. Iodine deficiency is a leading cause of mental retardation due to its significance in thyroid activity. Many table salts have added iodine, and certain foods such as seaweed contain high concentrations of iodine.
  • Selenium. Selenium is a necessary component of the enzyme that converts T4 to T3. Patients with various thyroid disorders were shown to have lower selenium levels.
  • Zinc. Zinc may contribute to the conversion of T4 to T3. In a group of patients with abnormal thyroid hormone levels, zinc supplementation normalized the levels.
  • Iron. Iron deficiency hampers the production of thyroid hormone. One study showed subjects with subclinical hypothyroidism were more likely to be iron deficient than the control group.
  • Copper. Copper is important for normal brain development; deficiency can cause ineffective regulation of thyroid hormone. Rat studies showed that copper-deficient mothers gave birth to T3-deficient infants.
  • Vitamin E. Several preclinical studies indicate vitamin E may help reduce oxidative stress caused by hypothyroidism.
  • DHEA and pregnenolone. Patients with hypothyroidism may have significantly lower levels of DHEA and pregnenolone than people with normal thyroid function.
  • Ashwagandha extract. Ashwagandha extracts have been used for centuries in Ayurvedic medicine to alleviate stress. A small study indicated that the extract also improved thyroid function and thyroid-related hormone levels.
  • Korean ginseng. Korean ginseng extract has shown promise in multiple clinical trials for a variety of conditions. In a trial of subjects with congestive heart failure and low T3 and T4, intravenous ginseng extract increased levels of both hormones.
  • Vitamin A. Vitamin A (a family of related retinoic acids including retinol and beta-carotene) is important for thyroid health, and deficiencies are associated with thyroid dysfunction.
  • Other natural interventions for thyroid health and function include guggul extract, vitamin D, vitamin B12, turmeric, and Rhodiola rosea.

2 Introduction

Millions of Americans suffer from fatigue, weight gain, depression, and cognitive impairment. Many believe that they have no choice but to accept these seemingly “age-related” declines in quality of life.

Underactive thyroid (hypothyroidism) is often overlooked or misdiagnosed and can be the underlying cause of these symptoms. Patients and their doctors often disregard these common signs of thyroid hormone deficiency, mistaking them for normal aging.1

Overactive thyroid (hyperthyroidism) afflicts fewer people than hypothyroidism, yet the symptoms can be equally devastating. Subclinical hyperthyroidism, characterized by suppressed thyroid stimulating hormone (TSH) levels accompanied by normal thyroid hormones (T4 and T3) levels,2 has been associated with increased rates of cardiovascular disease; arrhythmia in particular.3 Overt hyperthyroidism compromises bone health,4 elevates blood glucose levels,5 and often causes anxiety.6

Fortunately, a simple blood test for TSH, T3 and T4 can reveal an underlying thyroid condition and help direct treatment to improve the symptoms.1, 2

In this protocol we will discuss the function and regulation of the thyroid gland, and the systemic implications of both hypothyroidism and hyperthyroidism. We will examine the importance of proper testing and interpretation of thyroid hormone levels and reveal natural approaches for maintaining optimal thyroid hormone levels.

3 Role of the Thyroid

The thyroid is a butterfly-shaped organ located just below the Adam’s apple in the neck. Made up of small sacs, this gland is filled with an iodine-rich protein called thyroglobulin along with the thyroid hormones thyroxine (T4) and small amounts of triiodothyronine (T3).

The primary function of these two hormones is to regulate metabolism by controlling the rate at which the body converts oxygen and calories to energy. In fact, the metabolic rate of every cell in the body is regulated by thyroid hormones, primarily T3.7

In healthy individuals the gland is imperceptible to the touch. A visibly enlarged thyroid gland is referred to as a goiter. Historically, goiter was most frequently caused by a lack of dietary iodine.8 However, in countries where salt is iodized, goiter of iodine deficiency is rare.

4 Thyroid Regulation

The production of T4 and T3 in the thyroid gland is regulated by the hypothalamus and pituitary gland. To ensure stable levels of thyroid hormones, the hypothalamus monitors circulating thyroid hormone levels and responds to low levels by releasing thyrotropin-releasing hormone (TRH). This TRH then stimulates the pituitary to release thyroid stimulating hormone (TSH).9,10 When thyroid hormone levels increase, production of TSH decreases, which in turn slows the release of new hormone from the thyroid gland.

Cold temperatures can also increase TRH levels. This is thought to be an intrinsic mechanism that helps keep us warm in cold weather.11

Elevated levels of cortisol, as seen during stress and in conditions such as Cushing’s syndrome, lowers TRH, TSH and thyroid hormone levels as well.12,13

The thyroid gland needs iodine and the amino acid L-tyrosine to make T4 and T3. A diet deficient in iodine can limit how much T4 the thyroid gland can produce and lead to hypothyroidism.14

T3 is the biologically active form of thyroid hormone. The majority of T3 is produced in the peripheral tissues by conversion of T4 to T3 by a selenium-dependent enzyme. Various factors including nutrient deficiencies, drugs, and chemical toxicity may interfere with conversion of T4 to T3.15

Another related enzyme converts T4 to an inactive form of T3 called reverse T3 (rT3). Reverse T3 does not have significant thyroid hormone activity.16

Ninety-nine percent of circulating thyroid hormones are bound to carrier proteins, rendering them metabolically inactive. The remaining “free” thyroid hormone, the majority of which is T3, binds to and activates thyroid hormone receptors, exerting biological activity.17 Very small changes in the amount of carrier proteins will affect the percentage of unbound hormones. Oral contraceptives, pregnancy, and conventional female hormone replacement therapy may increase thyroid carrier protein levels and, thereby, lower the amount of free thyroid hormone available.18

5 Thyroid Dysfunction


In hyperthyroidism, the thyroid gland produces too much thyroid hormone, which can significantly accelerate the body's metabolism. Typical symptoms of hyperthyroidism include sudden weight loss, a rapid heartbeat, sweating, nervousness or irritability. Hyperthyroidism affects about one percent of the population.19

Extreme hyperthyroidism, or thyrotoxicosis, can culminate in what’s referred to as “thyroid storm.”20 In this medical emergency, patients suffer from elevated heart rates and blood pressure, extreme exhaustion, and high fever. Thyroid storm sharply increases a patient’s risk for stroke and heart attack, and is fatal for up to 50% of patients, even with the best medical care.21

Hyperthyroidism: What you need to know

Hyperthyroidism is usually caused by Graves’ disease characterized by symptoms such as rapid heartbeat, sweating, nervousness, tremors, muscle weakness, sleep difficulties, increased appetite and sudden weight loss.22 Affected individuals can also experience thyroid storm—a potentially deadly medical emergency.23

Medical Treatment of Grave’s disease24

  • Anti-thyroid drugs, such as methimazole or propylthiouracil, inhibit the production of T3.
  • Radioactive iodine, which causes destruction of the overactive thyroid gland.
  • Surgical removal of the thyroid gland (thyroidectomy).
  • Βeta-blockers may be used to control the high blood pressure and increased heart rate associated with hyperthyroidism.

Nutritional Support of Hyperthyroidism

  • Increased thyroid activity increases loss of L-carnitine through the urine. Individuals suffering from hyperthyroidism may, therefore, require supplemental L-carnitine.25
  • L-carnitine supplementation helped prevent or reverse muscle weakness and other symptoms in individuals suffering from hyperthyroidism. Clinical trials have shown that doses of 2,000-4,000 mg/day of L-carnitine are helpful in individuals who suffer from hyperthyroidism.26
  • Passion flower (Passiflora incarnata ) and valerian (Valeriana officinalis) are botanicals that have a calming effect on the nervous system27,28 and thus may help control the symptoms of an overactive thyroid.


Hypothyroidism is a condition in which the thyroid gland does not make enough thyroid hormones, characterized by a reduction in metabolic rate. The main symptoms of hypothyroidism are fatigue, weakness, increased sensitivity to cold, constipation, unexplained weight gain, dry skin, hair loss or coarse dry hair, muscle cramps and depression. However, most symptoms take years to develop. The slower the metabolism gets, the more obvious the signs and symptoms will become. If hypothyroidism goes untreated, the signs and symptoms could become severe, such as a swollen thyroid gland (goiter), slow thought processes, or dementia.29

Subclinical hypothyroidism, an often under-diagnosed thyroid disorder, manifests as elevated TSH, normal T4 and normal T3 levels.30 Individuals with subclinical hypothyroidism are at greater risk for developing overt hypothyroidism.31 An August 2010 study reported that 8.3% of women with no history of thyroid disease suffer from subclinical hypothyroidism.32 An article in the American Family Physician in 2005 estimated that about 20% of women over the age of 60 suffer from subclinical hypothyroidism.33

There is evidence that the standard blood TSH test reference range may cause many cases of hypothyroidism to be missed. Most physicians accept a reference range for TSH between 0.45 and 4.5 µIU/mL to indicate normal thyroid function. In reality, though, a TSH reading of more than 2.0 may indicate lower-than-optimal thyroid hormone levels.34

According to a report in Lancet, various TSH levels that fall within normal range are associated with adverse health outcomes.31

  • TSH greater than 2.0: increased 20-year risk of hypothyroidism and increased risk of thyroid autoimmune disease
  • TSH between 2.0 and 4.0: hypercholesterolemia and cholesterol levels decline in response to T4 therapy
  • TSH greater than 4.0: greater risk of heart disease

There is another and separate problem brought on by these overly broad normal ranges for TSH. People already diagnosed and being treated for hypothyroidism are often not taking correct doses of thyroid replacement hormone. A November 2010 study reported that about 37% of people being treated for hypothyroidism were taking incorrect doses, about half too much and another half too little hormone.35

6 Consequences of Hypothyroidism

Gastrointestinal problems. Hypothyroidism is a common cause of constipation. Constipation in hypothyroidism may result from diminished motility of the intestines. In some cases, this can lead to intestinal obstruction or abnormal enlargement of the colon.36 Hypothyroidism is also associated with decreased motility in the esophagus, which causes difficulty swallowing, heartburn, indigestion, nausea, or vomiting. Abdominal discomfort, flatulence, and bloating occur in those with small intestinal bacterial growth secondary to poor digestion.31

Depression and psychiatric disorders. Panic disorders, depression, and changes in cognition are frequently associated with thyroid disorders.37 Hypothyroidism is often misdiagnosed as depression.38 A study published in 2002 suggests that that thyroid function is especially important for bipolar patients: “Our results suggest that nearly three-quarters of patients with bipolar disorder have a thyroid profile that may be suboptimal for antidepressant response.”39

Cognitive decline. Patients with low thyroid function can suffer from slowed thinking, delayed processing of information, difficulty recalling names, etc.40 Patients with subclinical hypothyroidism show signs of decreased working memory,41 and decreased speed of sensory and cognitive processing. 42 An evaluation of thyroid hormones along with TSH may help avoid misdiagnosis as being depressed.43

Cardiovascular Disease. Hypothyroidism and subclinical hypothyroidism are associated with increased levels of blood cholesterol, increased blood pressure, and increased risk of cardiovascular disease.44 Even those with subclinical hypothyroidism were almost 3.4 times as likely to develop cardiovascular disease than those with healthy thyroid function.45

  • High blood pressure. Hypertension is relatively common among patients with hypothyroidism. In a 1983 study, 14.8% of patients with hypothyroidism had high blood pressure, compared with 5.5% of patients with normal thyroid function.46 “Hypothyroidism has been recognized as a cause of secondary hypertension. Previous studies … have demonstrated elevated blood pressure values. Increased peripheral vascular resistance and low cardiac output has been suggested to be the possible link between hypothyroidism and diastolic hypertension.”47
  • High cholesterol and atherosclerosis. “Overt hypothyroidism is characterized by hypercholesterolemia and a marked increase in low-density lipoproteins (LDL) and apolipoprotein B.”48 These changes accelerate atherosclerosis, which causes coronary artery disease.43 The risk of heart disease increases proportionally with increasing TSH, even in subclinical hypothyroidism.49 Hypothyroidism that is caused by autoimmune reactions is associated with stiffening of the blood vessels.50 Thyroid hormone replacement may slow the progression of coronary heart disease by inhibiting the progression of plaques.51,52
  • Homocysteine. Treating hypothyroid patients with thyroid hormone replacement might attenuate homocysteine levels, an independent risk factor for cardiovascular disease: “A strong inverse relationship between homocysteine and free thyroid hormones confirms the effect of thyroid hormones on homocysteine metabolism.”53
  • Elevated C-reactive protein. Overt and subclinical hypothyroidism are both associated with increased levels of low-grade inflammation, as indicated by elevated C-reactive protein (CRP). A 2003 clinic study observed that CRP values increased with progressive thyroid failure and suggested it may count as an additional risk factor for the development of coronary heart disease in hypothyroid patients.54

Metabolic Syndrome. In a study of more than 1500 subjects, researchers found that those with metabolic syndrome had statistically significantly higher TSH levels (meaning lower thyroid hormone output) than healthy control subjects. Subclinical hypothyroidism was also correlated with elevated triglyceride levels and increased blood pressure. Slight increases in TSH may put people at higher risk for metabolic syndrome.55

Reproductive system problems. In women, hypothyroidism is associated with menstrual irregularities and infertility.56 Proper treatment can restore a normal menstrual cycle and improve fertility.57

Fatigue and weakness. The well-known and common symptoms of hypothyroidism, such as chilliness, weight gain, paresthesia (tingling or crawling sensation in the skin) and cramps are often absent in elderly patients compared with younger patients, fatigue and weakness are common in hypothyroid patients.58

7 Testing Thyroid Function

Thyroid stimulating hormone (TSH). TSH level is the most common test for screening for thyroid dysfunction. In the last decade the diagnostic strategy for using TSH measurements has changed as a result of the sensitivity improvements in these assays. It is now recognized that the TSH measurement is a more sensitive test than T4 for detecting both hypo- and hyperthyroidism.59 As a result, some countries now promote a TSH-first strategy for diagnosing thyroid dysfunction in patients.60

In 2008 many labs adopted the reference range for TSH, 0.45 to 4.50 μIU/mL, recommended by both the Endocrine Society and the American Medical Association. Although this range is an improvement over the previous 0.45-5.5 mIU/L, it is still considered too broad by many clinicians.59,60,61

The American Association of Clinical Endocrinologists now recommends an upper limit of 3.0 mIU/L.61 The guidelines for diagnosing thyroid disease from The National Academy of Clinical Biochemistry point out that "more than 95% of normal individuals have TSH levels below 2.5 [µIU/mL]."62 This panel suggests that the upper limit of TSH should be reduced to 2.5 µIU/mL.63

On the other hand, current studies also suggest that TSH values below the normal range may represent thyroid hormone excess and, in elderly patients, might be associated with an increased risk of death due to cardiovascular disease.64,65

Life Extension suggests an optimal level of TSH between 1.0 and 2.0 µIU/mL, as some studies have noted that a TSH above 2.0 may be associated with adverse cardiovascular risk factors.26 In addition, a TSH between 1.0 and 2.0 µIU/mL has been associated with the lowest subsequent incidence of abnormal thyroid function.66

However, while a measure of TSH alone is a useful screening tool in assessing thyroid function, Life Extension advocates additional testing, including Free T3 and T4 levels, to provide a more complete evaluation of the thyroid.

Note: TSH values do fluctuate with time of day, infection, and various other factors. In a 2007 survey published in the Archives of Internal Medicine, values spontaneously returned to normal in more than 50% of patients with abnormal TSH levels when the test was repeated at a later date.67 No single measurement of TSH should be considered diagnostic.

Basal Body Temperature. An alternative method for assessing thyroid status that was widely used in the past, before the development of accurate thyroid function blood tests, is the basal body temperature test. The temperature is taken when the body is at complete rest, immediately after waking and before beginning any activity. The normal basal temperature is 97.6-98.2 ºF, and some alternative practitioners believe that a 5-day consecutive temperature reading below 97.6 ºF is indicative of hypothyroidism. One study showed a significant correlation between the basal body temperature and low thyroid function in whiplash patients. The authors of this study conclude that basal body temperature “seems to be a sensitive screening test, in combination with laboratory analysis, for the hypothyroidism seen after whiplash trauma.”68 However, there are many reasons for alteration of basal body temperature, a thyroid panel blood test should be taken to accurately evaluate the thyroid function.

Tests for T4 and T3. Thyroid hormones can be tested in both their free and protein-bound forms. Tests for the protein-bound forms and unbound form of T4 or T3 are generally referred to as Total T4 or Total T3 respectively; unbound forms are called Free T4 and Free T3. Each of these tests gives information about how the body is making, activating, and responding to thyroid hormone. Levels of free T3 and T4 will be below normal in clinical hypothyroidism. In subclinical hypothyroidism the TSH will be elevated while the thyroid hormone levels are still in the normal reference range.

Reverse T3. Certain individuals with apparently normal T4 and T3 hormone levels still display the classic symptoms of hypothyroidism. This may be due to an excessive production of reverseT3 (rT3). rT3 is inactive and may interfere with the action of T3 in the body. Stress and extreme exercise may play a role in lowering thyroid hormone action by suppressing production of TSH and T3 and elevating rT3 levels.69,70

Autoimmune antibodies. When evaluating the thyroid it is also important to consider that the most common cause of overt hypothyroidism in the United States is an autoimmune disorder known as Hashimoto’s thyroiditis.71 In this condition the body produces antibodies to the thyroid gland and damage the gland. Hashimoto’s thyroiditis is diagnosed by standard thyroid testing in conjunction with testing for the presence of these antibodies called antithyroglobulin antibodies (AgAb) and thyroperoxidase antibodies (TPOAb). Some people with celiac disease or sensitivity to gluten are at increased risk for developing autoimmune thyroid disease and should be evaluated.72

Elevated thyroid antibodies are often associated with chronic urticaria, also called hives. Studies report that as many as 57.4% of patients with hives have the presence of anti-thyroid antibodies.73,74 An August 2010 paper suggests that treatment with T4 improves the itching associated with urticaria, but did not advise treatment with T4 unless the patient was hypothyroid.75

Additional testing. Sometimes biopsy or enzymatic studies are required to establish a definite diagnosis for thyroid dysfunction. Major abnormalities of the thyroid gland detected in physical exam can be further assessed by ultrasound or a procedure known as scintigraphy.

Hypothalamic pituitary axis (HPA). There is an intimate relationship between the thyroid, the adrenal glands and the sex hormones.76 If hypothyroidism is suspected, an evaluation of the adrenal glands as well as the sex hormones is suggested.

Hypothyroidism: What you need to know

  • Thyroid diseases occur about five times more frequently in women than in men. As many as 20% of women over 60 years old have subclinical hypothyroidism.77
  • If untreated, chronic hypothyroidism can result in myxedema coma, a rare, life-threatening condition. Mental dysfunction, stupor, cardiovascular collapse, and coma can develop after the worsening of chronic hypothyroidism as well.78
  • An autoimmune disease called Hashimoto’s thyroiditis is the most common cause of low thyroid function in the United States. The body’s immune system mistakenly attacks the thyroid tissue impairing the ability to make hormones.79 Hypothyroidism caused by Hashimoto's disease is treated with thyroid hormone replacement agents.
  • Hashimoto’s disease usually causes hypothyroidism, but may also trigger hyperthyroid symptoms.80
  • Hyperthyroidism is usually caused by Graves’ disease, in which antibodies are produced that bind to TSH receptors in the thyroid gland, stimulating excess thyroid hormone production.20
  • The distinction between Hashimoto’s thyroiditis and Graves’ disease may not be as important as once thought. In 2009 researchers wrote that, “Hashimoto's and Graves' disease are different expressions of a basically similar autoimmune process, and the clinical appearance reflects the spectrum of the immune response in a particular patient.” 81 The two diseases can overlap causing both thyroid gland stimulation and destruction simultaneously or in sequence.82 Some clinicians consider the two conditions different presentations of the same disease.83 About 4% of patients with Graves’ disease displayed some symptoms of Hashimoto’s thyroiditis during childhood.84
  • Pregnant women are especially at risk for hypothyroidism. During pregnancy, the thyroid gland produces more thyroid hormone than when a woman is not pregnant,85 and the gland may increase in size slightly.
  • Uncontrolled thyroid dysfunction during pregnancy can lead to preterm birth, mental retardation, and hemorrhage in the postpartum period.86 It is important to work closely with a physician to monitor thyroid function during pregnancy.
  • Tests to diagnose and monitor hypothyroidism include: Thyroid Stimulating Hormone (TSH), Total T4, Total T3, Free T4 (fT4), Free T3 (fT3), Reverse T3 (rT3), Thyroid peroxidase antibody (TPOAb), Thyroglobulin antibody (TgAb)

8 Thyroid Hormone Replacement

The most common treatment for low thyroid hormone levels consists of thyroid hormone replacement therapy. The goal of thyroid hormone replacement is to relieve symptoms and to provide sufficient thyroid hormone to decrease elevated TSH levels to within the normal range.87

Conventional treatment almost always begins with synthetic T4 (levothyroxine) preparations like Synthroid® or Levoxyl®. Low doses are usually used at first because a rapid increase in thyroid hormone may result in cardiac damage.88

Sometimes hypothyroid symptoms persist despite T4 treatment. In a 2001 study, T4 therapy was no more effective than placebo in improving cognitive function and psychological well-being in patients with symptoms of hypothyroidism, despite improvement in free T3 levels.89 A December 2010 study compared the T3 and T4 levels of hypothyroid patients treated with T4 alone against the levels found in healthy people and reported that T4 supplementation alone did not increase T3 to the same level as found in healthy people.90 As you will read later, deficiencies in nutrients like selenium can disable the body from converting T4 to biologically active T3.

In an animal study, rats with the thyroid gland removed were treated with T4 alone. The researchers found that no single dose restored normal concentrations of TSH, T4, and T3 in the blood, tissues and organs.91 The following year the same authors reported that a combination of T4 and T3 was able to normalize hormone levels in both blood and tissues.92 Other studies have failed to demonstrate any advantage of the combination therapy, although the results do suggest the possibility of a subset of hypothyroid patients who would benefit from combination therapy.93,94

One combination option is a drug called Thyrolar, which combines synthetic T3 and T4 in a fixed 1:4 ratio. Caution should be used, however, in administering T3 to older individuals because excess T3 may cause adverse cardiac events in this population.95

Another T3 option is a drug called Cytomel®, which is a synthetic form of T3. This can be used in combination with T4.

Desiccated Thyroid. Armour thyroid, Nature-throid, and Westhroid are prescription medications that contain desiccated porcine thyroid gland. Natural thyroid extracts have been used since 1892 and were approved by the Food and Drug Administration in 1939. Armour thyroid and most other natural glandular preparations are made to standards approved by the United States Pharmacopoeia.

Armour thyroid is preferred by some clinicians because it may achieve results in patients that fail to respond to levothyroxine alone. Patients with hypothyroidism show greater improvements in mood and brain function if they receive treatment with Armour thyroid rather than Synthroid®.96 One argument favoring natural hormones is that other naturally occurring hormones and chemicals found in these preparations may buffer or enhance the effect of the active hormones.87,92

Ultimately, there may not be a single correct approach to low thyroid hormone levels. Instead, the best option may be to monitor thyroid levels through regular blood testing and systematically try various protocols to see what yields the best resolution of symptoms. Some people may prefer to begin with desiccated thyroid, while others may find it preferable to begin with T4 supplementation then move to a combination T3-T4 therapy if they experience no improvement from T4 alone.

Absorption of Thyroid Hormone Medications. Coffee,97 aluminum antacids,98 ferrous sulfate (iron),99 calcium carbonate,100 soy101 and possibly grapefruit juice102 can all decrease the absorption of thyroid hormone prescriptions. Most doctors simply advise patients to take thyroid hormone away from any food or medication.

While most people take thyroid hormone in the morning, a December 2010 paper suggests that it is more effective to take thyroid medication just before bed.103

9 Nutrients to Support Thyroid Function

Iodine. The body needs iodine to make thyroid hormone. As of the late 1990s, thirty-two European countries were still affected by iodine deficiency.104 In 2007 the WHO estimated that over 30% of the world’s population (2 billion people) has insufficient iodine intake as measured by urinary iodine excretion below 100 µg/L.105 Iodized salt has proven to be effective at preventing iodine deficiency. The Morton Salt Company began selling iodized salt in the United States in 1924.106

Hypothyroidism in the unborn child, congenital hypothyroidism or cretinism, is frequently caused by iodine deficiency. In industrialized countries the incidence is about 1 case in 4500 live births. Yet, the incidence of cretinism can increase to as much as 1 case in 20 live births in areas that have iodine deficiency.107 Because of this, iodine deficiency remains one of the leading causes of mental retardation.108

During pregnancy T4 production doubles, causing increases in daily iodine requirements.109 Iodine deficient pregnant women cannot produce the thyroid hormones that are needed for proper neurological development of their growing babies, and are at high risk of giving birth to infants with cognitive impairment and learning delay. Even moderate iodine deficiency in a pregnant woman can lower her infant’s IQ from 8 to 16 points.110, 111

People who avoid iodized salt or adhere to a salt-restricted diet may become iodine deficient.112 Vegetarians are also at risk of developing iodine deficiency, especially if they eat food grown in low iodine soil.113 Vegans that avoid sea vegetables, are also at higher risk.114

Diets both low and high in iodine are associated with hypothyroidism. This is supported by studies that have shown that both low and high urinary iodine excretion are associated with hypothyroidism.115 High intake of iodine also increases the risk of Hashimoto’s thyroiditis.116

Iodine or foods high in iodine, such as seaweed, are thought useful in treating hypothyroidism but this is probably only true for people who are iodine deficient.113, 114 The upper intake level (UL) of iodine for adults is 1.1mg per day. However, iodine ingestion above this amount is generally well tolerated.117

The amount of supplemental iodine needed for an individual varies widely based on the factors previously listed. It is important to test thyroid function when supplementing with iodine since both low and excessively high intake can contribute to thyroid dysfunction.

Selenium. After iodine, selenium is probably the next most important mineral affecting thyroid function. The thyroid contains more selenium by weight than any other organ.118 Selenium is a necessary component of the enzymes that remove iodine molecules from T4 converting it into T3; without selenium there would be no activation of thyroid hormone. When patients suffering from various forms of thyroid disease were tested for selenium levels, all were found to be lower than normal healthy people.119 Some researchers suggest that selenium supplementation will improve conversion of T4 to T3.120 Selenium also plays a role in protecting the thyroid gland itself. The cells of the thyroid generate hydrogen peroxide and use it to make thyroid hormone. Selenium protects the thyroid gland from the oxidative damage caused by these reactions. Without adequate selenium, high iodine levels lead to destruction of the thyroid gland cells.121,122

People living in areas with low soil selenium content are more likely to develop Hashimoto's disease.123 This may be because a selenium deficiency makes the enzyme glutathione peroxidase less effective.124 Thus selenium supplementation has been suggested for treating Hashimoto’s disease.125

In a placebo controlled study published in 2002, researchers in Germany reported on an experiment in which they gave 200 mcg of sodium selenite daily to patients with Hashimoto's disease and high levels of thyroid peroxidase antibodies. After three months, the thyroid peroxidase antibody levels of the patients taking selenium were decreased by 66.4% compared to their pre-treatment values, and antibody levels returned to normal in nine of the selenium treated patients.126 Austrian researchers reported in 2008 that they were unable to duplicate the results of the earlier study when they did not limit the study population to those with high levels of thyroid peroxidase antibodies. They suggest that selenium supplementation might be of greater benefit to patients with higher disease activity.127

Selenium deficiency is also common in celiac disease, and this may be the tie-in to increased frequency of thyroid problems with celiac disease.128

During severe or prolonged infection, blood levels of selenium, T4, T3 and TSH decrease and the conversion of T4 to T3 slows, inducing a hypothyroid state.129 Because the enzymes that moderate this conversion require selenium, it has been hypothesized that supplementing extra selenium might prevent this decrease in T3 during illness. Supplying extra selenium may decrease mortality from infection, but it does not normalize thyroid hormone levels.130 It seems that the suppression of T3 during sickness is mediated by cytokines, in particular interleukin-6 (IL-6).131 It may be that IL-6 and other cytokines, generated by the infection, limit production of the selenium-enzymes and interfere with hormone production.

Zinc. Zinc may be helpful in patients with low T3 and may contribute to conversion of T4 to T3. In animal studies, zinc deficiency lowered T3 and free T4 concentrations by approximately 30%. Levels of total T4 were not affected by zinc deficiency.132 In a group of patients with low levels of free T3 and normal T4, but elevated rT3 and mild to moderate Zn deficiency, taking oral zinc supplements for 12 months, normalized the serum free T3 and total T3 levels, decreased the rT3 and normalized TSH levels.133

On the other hand, like iodine, too much zinc may suppress thyroid function.134 Very high doses of zinc interfere with copper absorption and can lead to serious and potentially fatal copper deficiency.135,136,137 Thus it is advised to take copper when supplementing with zinc.

Iron. Iron deficiency hinders manufacture of thyroid hormone by reducing activity of the enzyme thyroid peroxidase. In one study 15.7% of women with subclinical hypothyroidism were iron deficient, compared to only 9.8 % of the control group.138 Iron-deficiency anemia decreases, and iron supplementation improves, the beneficial effects of iodine supplementation.139 Treating iron deficient hypothyroid patients with levothyroxine (T4) along with iron improves their iron deficiency anemia more than treatment with iron alone.140

Copper. An August 2010 study revealed that copper is important for normal brain development and its deficiency leaves the hypothalamus unable to regulate thyroid hormone effectively. Copper deficient pregnant rats give birth to infant rats that produce 48% less T3 than those born from healthy mothers.141

Vitamin E. Vitamin E may reduce the oxidative stress caused by hypothyroidism. In one animal study, vitamin E was shown to protect animals from increased oxidation and thyroid cell damage.142 In another study, vitamin E reduced the amount of thyroid cell replication in animals with induced hypothyroidism.143

Vitamin D. Deficiency of vitamin D may increase risk of autoimmune thyroid disease. When adjusted for age, presence of thyroid antibodies was inversely correlated with vitamin D levels in a group of 642 participants (244 males and 398 females) in New Delhi, India.144 Moreover, other evidence suggests that vitamin D deficiency is more common among individuals with thyroid cancer or thyroid nodules, compared to the general population.145 Given the many benefits of adequate vitamin D, it makes sense to supplement if needed.

Vitamin B12. Hypothyroid patients are often vitamin B12 deficient. In a 2008 paper, Pakistani doctors reported that of 116 hypothyroid patients tested for vitamin B12, approximately 40% were deficient.146 It is not clear what the link between B12 deficiency and low thyroid function is, nor if thyroid function will improve with B12 supplementation.147 But, since low B12 causes serious neurologic damage, all hypothyroid patients should be tested.

DHEA and Pregnenolone. Japanese researchers reported that concentrations of DHEA, DHEA-sulfate, and pregnenolone-sulfate are significantly lower in hypothyroid patients compared to age and sex matched healthy controls.148

Turmeric (Curcuma longa) Extract. A 2002 study, using rats, found that treatment with turmeric extract reduced the impact of chemically induced hypothyroidism in terms of thyroid weight, T4, T3 and cholesterol levels.149 Results of a similar trial on rats treated with vitamin E and curcumin, a component found in turmeric, showed that treatment prevented a decline in basal body temperature and protected the liver.150

Rhodiola rosea. Given the fact that stress can influence thyroid status, it may be beneficial for some individuals with hypothyroidism to consider adaptogenic herbs such as Rhodiola.151,152 Adaptogenic herbs support the adrenal glands and can improve the body’s response to stress.153

Ashwagandha extract. Ashwagandha (Withania somnifera), also called winter cherry or Indian ginseng, is one of the most important herbs in traditional Ayurvedic medicine.164 Extracts of ashwagandha have been used for centuries in the Ayurvedic system as an adaptogen to alleviate physical and mental stress.165 Extracts of ashwagandha have been prepared from the leaves, berries, and roots of the plant. Among the important chemical compounds found in ashwagandha are oligosaccharides and withanolide glycosides.166-168

Researchers studying the effects of ashwagandha extract on bipolar disorder also collected data on thyroid function. In this study, three individuals were treated for eight weeks with 500 mg per day of a standardized ashwagandha extract. All three experienced decreases in thyroid stimulating hormone, indicating improved thyroid function, and T4 levels increased by 7‒24% compared with baseline in the ashwagandha-treated patients.165

In a rodent study, ashwagandha root extract raised blood levels of both biologically active forms of thyroid hormone, T3 and T4. After 20 days of feeding with ashwagandha root extract, T3 levels increased by 18% and T4 levels increased by 111%.169

Korean ginseng extract. Korean ginseng (Panax ginseng, family Araliaceae) is a native perennial plant of Asia and North America that has been an integral part of traditional Asian medicine. It has been in use for thousands of years and shown promise, in clinical trials, for diabetes, pulmonary disease, fatigue, improving immune function, and other conditions.170-173 Korean ginseng contains a wide range of bioactive components including at least 112 saponins, most of which are glycosides of triterpenoid aglycones. The class of saponins called ginsenosides have received a great deal of research interest and are believed to be among the most important bioactive compounds in Korean ginseng.174

In a placebo-controlled trial in 54 adults with congestive heart failure and abnormally low levels of T3 and T4, administration of intravenous ginseng extract resulted in increased T3 and T4 levels as well as reduced inactive and thyroid hormone-inhibiting reverse tri-iodothyronine (rT3) levels two weeks after infusion.175 Korean ginseng has also been shown to improve symptoms of cold hands and feet, which can be indicative of suboptimal thyroid function. Specifically, 80 women with cold hypersensitivity of the hands and feet were given 500 mg Korean ginseng daily for a period of eight weeks; at the end of the trial, subjects had substantially higher skin temperature in both their hands and feet.176

An enzymatically-fermented ginseng extract has been developed that provides a highly bioavailable ginsenoside metabolite as well as markedly enhanced bioavailability. Compared with non-fermented ginseng, the fermented preparation resulted in 15.5 times greater absorption of this ginsenoside in 24 hours, a 27-fold higher peak concentration in blood, and reached that peak in roughly a quarter of the time (3.29 hours vs. 12.04 hours). Several studies have demonstrated ginsenoside metabolites may have higher biological activity compared with unmetabolized ginsenosides. It is believed that unmetabolized ginsenosides are poorly bioavailable, and that orally consumed unmetabolized ginsenosides are inefficiently metabolized by stomach acid and liver enzymes.177-180

Guggul extract. Guggul is the gum resin of the mukul myrrh tree (Commiphora mukul or Commiphora wightii). Guggul has been used in traditional Ayurvedic medicine to treat tumors, obesity, lipid disorders, and other conditions. Guggulsterones are thought to be the most important bioactive compounds in guggul extract.181-183

A laboratory study showed an extract of Commiphora mukul significantly increased iodine uptake, T3 resin uptake, protein bound iodine, and free T4 levels in thyroid tissue.184 In a rodent study, rats given guggulsterone derived from Commiphora mukul exhibited an increase in thyroid gland activity as evidenced by increased iodine uptake and enhanced thyroid enzyme function.185 An extract of Commiphora mukul reversed experimentally-induced hypothyroidism in mice.186 This effect appears to have been mediated through enhanced production of T3 and a reduction in hepatic oxidative stress.186,187

Vitamin A. Vitamin A is one of the four fat-soluble vitamins necessary for human cellular processes. Vitamin A refers to family of structurally related retinoic acids including beta-carotene, retinol, retinal, retinyl esters (including retinyl palmitate), and beta-carotene (a provitamin).188

Vitamin A is important for appropriate thyroid function, and vitamin A deficiency is associated with thyroid dysfunction.189,190 Vitamin A deficiency has been demonstrated to result in thyroid gland structural changes in rodents and disrupt the delicate and critical interaction of the hypothalamic pituitary axis with thyroid hormone metabolism.191,192 Conversely, inadequate thyroid function can impair the conversion of beta-carotene into the biologically active vitamin A.193

In a four-month randomized controlled trial, premenopausal women who received 25 000 IU per day of vitamin A as retinyl palmitate had significant increases in serum T3 and decreases in serum TSH levels, a result authors concluded might reduce the risk of subclinical hypothyroidism.194

10 Dietary Recommendations

Some foods contain goitrogenic substances that reduce the utilization of iodine. These foods include canola oil, vegetables from the Brassica family (eg, cabbage,154 brussels sprouts,155 cassava,156 and millet157). The actual content of goitrogens in these foods is relatively low, however, and cooking significantly reduces the impact of these goitrogens on thyroid function.158

Studies show conflicting information concerning the impact of soy on the thyroid. Isoflavone molecules in soy do inhibit an enzyme involved in thyroid hormone synthesis,159,160 but that has not translated into poor thyroid function in otherwise healthy individuals with adequate iodine intake.161,162,163

For those with hypothyroidism, raw goitrogenic foods and soy foods that have not undergone fermentation and/ or food processing should be consumed in moderation and discontinued if symptoms should appear.

Disclaimer and Safety Information

This information (and any accompanying material) is not intended to replace the attention or advice of a physician or other qualified health care professional. Anyone who wishes to embark on any dietary, drug, exercise, or other lifestyle change intended to prevent or treat a specific disease or condition should first consult with and seek clearance from a physician or other qualified health care professional. Pregnant women in particular should seek the advice of a physician before using any protocol listed on this website. The protocols described on this website are for adults only, unless otherwise specified. Product labels may contain important safety information and the most recent product information provided by the product manufacturers should be carefully reviewed prior to use to verify the dose, administration, and contraindications. National, state, and local laws may vary regarding the use and application of many of the therapies discussed. The reader assumes the risk of any injuries. The authors and publishers, their affiliates and assigns are not liable for any injury and/or damage to persons arising from this protocol and expressly disclaim responsibility for any adverse effects resulting from the use of the information contained herein.

The protocols raise many issues that are subject to change as new data emerge. None of our suggested protocol regimens can guarantee health benefits. Life Extension has not performed independent verification of the data contained in the referenced materials, and expressly disclaims responsibility for any error in the literature.


  1. Canaris GJ, Steiner JF, Ridgway EC. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med. 1997 Sep;12(9):544-50.
  2. Leonard Wartofsky. Management of Subclinical Hyperthyroidism. J. Clin. Endocrinol. Metab. 2011 96: 59-61
  3. Vadiveloo T, Donnan PT, Cochrane L, Leese GP. The Thyroid Epidemiology, Audit, and Research Study (TEARS): Morbidity in Patients with Endogenous Subclinical Hyperthyroidism. J Clin Endocrinol Metab. 2011 Feb 23.
  4. Boonya-Ussadorn T, Punkaew B, Sriassawaamorn N. A comparative study of bone mineral density between premenopausal women with hyperthyroidism and healthy premenopausal women. J Med Assoc Thai. 2010 Nov;93 Suppl 6:S1-5.
  5. Dimitriadis G, Hatziagelaki E, Mitrou P, Lambadiari V, Maratou E, Raptis AE, Gerich JE, Raptis SA. Effect of Hyperthyroidism on Clearance and Secretion of Glucagon in Man. Exp Clin Endocrinol Diabetes. 2011 Jan 24.
  6. Leonard Wartofsky. Management of Subclinical Hyperthyroidism. J. Clin. Endocrinol. Metab. 2011 96: 59-61
  7. Videla LA, Fernández V, Tapia G, Varela P. Thyroid hormone calorigenesis and mitochondrial redox signaling: upregulation of gene expression. Front Biosci. 2007 Jan 1;12:1220-8.
  8. Pearce EN. National trends in iodine nutrition: is everyone getting enough? Thyroid. 2007 Sep;17(9):823-7.
  9. Segerson TP, Kauer J, Wolfe HC, et al. Thyroid hormone regulates TRH biosynthesis in the paraventricular nucleus of the rat hypothalamus. Science. 1987 Oct 2;238(4823):78-80.
  10. Dyess EM, Segerson TP, Liposits Z, et al. Triiodothyronine exerts direct cell-specific regulation of thyrotropin-releasing hormone gene expression in the hypothalamic paraventricular nucleus. Endocrinology. 1988 Nov;123(5):2291-7.
  11. Arancibia S, Rage F, Astier H, Tapia-Arancibia L. Neuroendocrine and autonomous mechanisms underlying thermoregulation in cold environment. Neuroendocrinology. 1996 Oct;64(4):257-67.
  12. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002 Oct;53(4):865-71.
  13. Roelfsema F, Pereira AM, Biermasz NR, et al. Diminished and irregular TSH secretion with delayed acrophase in patients with Cushing's syndrome. Eur J Endocrinol. 2009 Nov;161(5):695-703.
  14. Angermayr L, Clar C. Iodine supplementation for preventing iodine deficiency disorders in children. Cochrane Database Syst Rev. 2004;(2):CD003819.
  15. Kelly GS. Peripheral metabolism of thyroid hormones: a review. Altern Med Rev. 2000 Aug;5(4):306-33.
  16. Köhrle J. Thyroid hormone deiodinases--a selenoenzyme family acting as gate keepers to thyroid hormone action. Acta Med Austriaca. 1996;23(1-2):17-30.
  17. Nussey S, Whitehead S. Endocrinology: An Integrated Approach. Oxford: BIOS Scientific Publishers; 2001. Box 3.28. Available at:
  18. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med. 2001 Jun 7;344(23):1743-9.
  19. Vadiveloo T, Donnan PT, Cochrane L, Leese GP. The Thyroid Epidemiology, Audit, and Research Study (TEARS): the natural history of endogenous subclinical hyperthyroidism. J Clin Endocrinol Metab. 2011 Jan;96(1):E1-8.
  20. Nayak B, Burman K. Thyrotoxicosis and thyroid storm. Endocrinol Metab Clin North Am. 2006 Dec;35(4):663-86
  21. Burch HB, Wartofsky L. Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am. 1993 Jun;22(2):263-77.
  22. Walling HW. Clinical differentiation of primary from secondary hyperhidrosis. J Am Acad Dermatol. 2011 Feb 17.
  23. Nayak B, Burman K. Thyrotoxicosis and thyroid storm. Endocrinol Metab Clin North Am. 2006 Dec;35(4):663-86, vii.
  24. Streetman DD, Khanderia U. Diagnosis and treatment of Graves disease. Ann Pharmacother. 2003 Jul-Aug;37(7-8):1100-9.
  25. Sinclair C, Gilchrist JM, Hennessey JV, Kandula M. Muscle carnitine in hypo- and hyperthyroidism. Muscle Nerve. 2005 Sep;32(3):357-9.
  26. Benvenga S, Ruggeri RM, Russo A, Lapa D, Campenni A, Trimarchi F. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2001 Aug;86(8):3579-94.
  27. Deng J, Zhou Y, Bai M, Li H, Li L. Anxiolytic and sedative activities of Passiflora edulis f. flavicarpa.J Ethnopharmacol. 2010 Mar 2;128(1):148-53.
  28. Weeks BS. Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian.Med Sci Monit. 2009 Nov;15(11):RA256-62.
  29. Hypothyroidism. The American Thyroid Association. Accessed March 18, 2011.
  30. Garduño-Garcia Jde J, Alvirde-Garcia U, López-Carrasco G, et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 2010 Aug;163(2):273-8.
  31. Dayan CM, Saravanan P, Bayly G. Whose normal thyroid function is better—yours or mine? Lancet. 2002 Aug 3;360(9330):353.
  32. Garduno-Garcia Jde J et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 2010 Aug;163(2):273-8.
  33. Wilson GR, Curry RW Jr. Subclinical thyroid disease. Am Fam Physician. 2005 Oct 15;72(8):1517-24.
  34. Tunbridge WM, Evered DC, Hall R, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977 Dec;7(6):481-93.
  35. Okosieme OE, Belludi G, Spittle K, Kadiyala R, Richards J. Adequacy of thyroid hormone replacement in a general population. QJM. Epub 2010 Nov 24.
  36. Ebert EC. The thyroid and the gut. J Clin Gastroenterol. 2010 Jul;44(6):402-6.
  37. Romaldini JH, Sgarbi JA, Farah CS. Subclinical thyroid disease: subclinical hypothyroidism and hyperthyroidism. Arq Bras Endocrinol Metabol. 2004 Feb;48(1):147-58.
  38. Hennessey JV, Scherger JE. Evaluating and treating the patient with hypothyroid disease. J Fam Pract. 2007 Aug;56(8 Suppl Hot Topics):S31-9.
  39. Cole DP, Thase ME, Mallinger AG, et al. Slower treatment response in bipolar depression predicted by lower pretreatment thyroid function. Am J Psychiatry. 2002 Jan;159(1):116-21.
  40. Hogervorst E, Huppert F, Matthews FE, Brayne C. Thyroid function and cognitive decline in the MRC Cognitive Function and Ageing Study. Psychoneuroendocrinology. 2008 Aug;33(7):1013-22.
  41. Samuels MH, Schuff KG, Carlson NE, et al. Health status, mood, and cognition in experimentally induced subclinical hypothyroidism. J Clin Endocrinol Metab. 2007 Jul;92(7):2545-51.
  42. Anjana Y, Tandon OP, Vaney N, Madhu SV. Cognitive status in hypothyroid female patients: event-related evoked potential study. Neuroendocrinology. 2008;88(1):59-66.
  43. Kritz-Silverstein D, Schultz ST, Palinska LA, Wingard DL, Barrett-Connor E. The association of thyroid stimulating hormone levels with cognitive function and depressed mood: the Rancho Bernardo study. J Nutr Health Aging. 2009 Apr;13(4):317-21.
  44. Kvetny J, Heldgaard PE, Bladbjerg EM, Gram J. Subclinical hypothyroidism is associated with a low-grade inflammation, increased triglyceride levels and predicts cardiovascular disease in males below 50 years. Clin Endocrinol (Oxf). 2004 Aug;61(2):232-8.
  45. Duntas LH, Biondi B. New insights into subclinical hypothyroidism and cardiovascular risk. Semin Thromb Hemost. 2011 Feb;37(1):27-34.
  46. Saito I, Ito K, Saruta T. Hypothyroidism as a cause of hypertension. Hypertension. 1983 Jan-Feb;5(1):112-5.
  47. Stabouli S, Papakatsika S, Kotsis V. Hypothyroidism and hypertension. Expert Rev Cardiovasc Ther. 2010 Nov;8(11):1559-65.
  48. Duntas LH. Thyroid disease and lipids. Thyroid. 2002 Apr;12(4):287-93.
  49. Rodondi N, den Elzen WPJ, Bauer DC, et al. Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality. JAMA. 2010;304(12):1365-1374.
  50. Stamatelopoulos KS, Kyrkou K, Chrysochoou E, et al. Arterial stiffness but not intima-media thickness is increased in euthyroid patients with Hashimoto's thyroiditis: The effect of menopausal status. Thyroid. 2009 Aug;19(8):857-62.
  51. Caparević Z, Bojković G, Stojanović D, Ilić V. Dyslipidemia and subclinical hypothyroidism. Med Pregl. 2003 May-Jun;56(5-6):276-80.
  52. Perk M, O'Neill BJ. The effect of thyroid hormone therapy on angiographic coronary artery disease progression. Can J Cardiol. 1997 Mar;13(3):273-6.
  53. Bicíková M, Hampl R, Hill M, et al. Steroids, sex hormone-binding globulin, homocysteine, selected hormones and markers of lipid and carbohydrate metabolism in patients with severe hypothyroidism and their changes following thyroid hormone supplementation. Clin Chem Lab Med. 2003 Mar;41(3):284-92.
  54. Christ-Crain M, Meier C, Guglielmetti M, Huber PR, Riesen W, Staub JJ, Müller B. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. Atherosclerosis. 2003 Feb;166(2):379-86.
  55. Lai Y, Wang J, Jiang F, Wang B, Chen Y, Li M, et al. The relationship between serum thyrotropin and components of metabolic syndrome. Endocr J. Epub 2010 Nov 30.
  56. Joshi JV, Bhandarkar SD, Chadha M, et al. Menstrual irregularities and lactation failure may precede thyroid dysfunction or goitre. J Postgrad Med. 1993 Jul-Sep;39(3):137-41.
  57. Poppe K, Velkeniers B, Glinoer D. Thyroid disease and female reproduction. Clin Endocrinol (Oxf). 2007 Mar;66(3):309-21.
  58. Doucet J, Trivalle C, Chassagne P, et al. Does age play a role in clinical presentation of hypothyroidism? J Am Geriatr Soc. 1994 Sep;42(9):984-6.
  59. Fatourechi V. Subclinical hypothyroidism: an update for primary care physicians. Mayo Clin Proc. 2009;84(1):65-71.
  60. Guan H, Shan Z, Teng X, et al. Influence of iodine on the reference interval of TSH and the optimal interval of TSH: results of a follow-up study in areas with different iodine intakes. Clin Endocrinol (Oxf). 2008 Jul;69(1):136-41..
  61. American Association of Clinical Endocrinologists. Subclinical thyroid disease. Accessed March 17, 2011.
  62. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab. 2005 Sep;90(9):5483-8.
  63. Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid. 2003 Jan;13(1):3-126.
  64. Sawin CT, Geller A, Kaplan MM, Bacharach P, Wilson PW, Hershman JM et al. Low serum thyrotropin (thyroid stimulating hormone) in older persons without hyperthyroidism. Arch Intern Med 1991;151:165-8.
  65. Parle JV, Maisonneuve P, Sheppard MC, Boyle P and Franklyn JA. Prediction of all-cause andcardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year study.Lancet 2001Sept 15;358:861-5.
  66. Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med. 2006 Jun 29;354(26):2783-93.
  67. Meyerovitch J, Rotman-Pikielny P, Sherf M, et al. Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians. Arch Intern Med. 2007 Jul 23;167(14):1533-8.
  68. Sehnert KW, Croft AC. Basal metabolic temperature vs. laboratory assessment in "posttraumatic hypothyroidism". J Manipulative Physiol Ther. 1996 Jan;19(1):6-12.
  69. Mastorakos G, Pavlatou M. Exercise as a stress model and the interplay between the hypothalamus-pituitary-adrenal and the hypothalamus-pituitary-thyroid axes. Horm Metab Res. 2005 Sep;37(9):577-84.
  70. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002 Oct;53(4):865-71.
  71. Lorini R, Gastaldi R, Traggiai C, Perucchin PP. Hashimoto's Thyroiditis. Pediatr Endocrinol Rev. 2003 Dec;1 Suppl 2:205-11; discussion 211.
  72. Meloni A, Mandas C, Jores RD, Congia M. Prevalence of autoimmune thyroiditis in children with celiac disease and effect of gluten withdrawal. J Pediatr. 2009 Jul;155(1):51-5, 55.e1.
  73. Najib U, Bajwa ZH, Ostro MG, Sheikh J. A retrospective review of clinical presentation, thyroid autoimmunity, laboratory characteristics, and therapies used in patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2009 Dec;103(6):496-501.
  74. Aamir IS, Tauheed S, Majid F, Atif A. Frequency of autoimmune thyroid disease in chronic urticaria. J Coll Physicians Surg Pak. 2010 Mar;20(3):158-61.
  75. Kiyici S, Gul OO, Baskan EB, et al. Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity. Clin Exp Dermatol. 2010 Aug;35(6):603-7.
  76. Tohei A. et al J Reprod Dev. Studies on the functional relationship between thyroid, adrenal and gonadal hormones. 2004 Feb;50(1):9-20.
  77. Wilson GR, Curry RW Jr. Subclinical thyroid disease. Am Fam Physician. 2005 Oct 15;72(8):1517-24.
  78. Jordan RM. Myxedema coma. Pathophysiology, therapy, and factors affecting prognosis. Med Clin North Am. 1995 Jan;79(1):185-94.
  79. The NationalWomen’s Health Information Center. Accessed March 17, 2011.
  80. Lorini R, Gastaldi R, Traggiai C, Perucchin PP. Hashimoto's Thyroiditis. Pediatr Endocrinol Rev. 2003 Dec;1 Suppl 2:205-11; discussion 211.
  81. Paknys G, Kondrotas AJ, Kevelaitis E. Risk factors and pathogenesis of Hashimoto's thyroiditis. Medicina (Kaunas). 2009;45(7):574-83.
  82. McLachlan SM, Nagayama Y, Pichurin PN, et al. The link between Graves' disease and Hashimoto's thyroiditis: a role for regulatory T cells. Endocrinology. 2007 Dec;148(12):5724-33.
  83. Selenkow HA, Wyman P, Allweiss P. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases. Compr Ther. 1984 Apr;10(4):48-56.
  84. Wasniewska M, Corrias A, Arrigo T, et al. Frequency of Hashimoto's thyroiditis antecedents in the history of children and adolescents with graves' disease. Horm Res Paediatr. 2010;73(6):473-6.
  85. Costeira MJ, Oliveira P, Ares S, Roque S, de Escobar GM, Palha JA. Parameters of thyroid function throughout and after pregnancy in an iodine-deficient population. Thyroid. 2010 Sep;20(9):995-1001.
  86. Drews K, Seremak-Mrozikiewicz A. The Optimal Treatment of Thyroid Gland Function Disturbances During Pregnancy. Curr Pharm Biotechnol.
  87. Clarke N, Kabadi UM. Optimizing treatment of hypothyroidism.Treat Endocrinol. 2004;3(4):217-21.
  88. Arnow WS. The heart and thyroid disease. Clin Geriatr Med. 1995May;11:219–29.
  89. Pollock MA, Sturrock A, Marshall K, et al. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial. BMJ. 2001 Oct 20;323(7318):891-5.
  90. Sesmilo G, Simó O, Choque L, et al. Serum free triiodothyronine (T3) to free thyroxine (T4) ratio in treated central hypothyroidism compared with primary hypothyroidism and euthyroidism. Endocrinol Nutr. Epub 2010 Dec 31.
  91. Escobar-Morreale HF, Obregón MJ, Escobar del Rey F, Morreale de Escobar G. Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. J Clin Invest. 1995 Dec;96(6):2828-38.
  92. Escobar-Morreale HF, del Rey FE, Obregón MJ, de Escobar GM. Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology. 1996 Jun;137(6):2490-502.
  93. Sawaka AM, Gerstein HC, et al. Does a combination regimen of thyroxine (T4) and 3,5,3’-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind randomized, controlled trial. J Clin Endocrinol Metab. 2003 Oct;88(10):4551–5.
  94. Walsh JP, Stuckey BG. What is the optimal treatment for hypothyroidism? Med J Aust. 2001Feb 5;174(3):41–3.
  95. Dhal P et al. Thyrotoxic cardiac disease. Curr Heart Fail Rep. 2008 Sep;5(3):170-6.
  96. Gaby AR. Sub-laboratory hypothyroidism and the empirical use of Armour thyroid. Altern Med Rev. 2004 Jun;9(2):157-79.
  97. Benvenga S, Bartolone L, Pappalardo MA, et al. Altered intestinal absorption of L-thyroxine caused by coffee.Thyroid. 2008 Mar;18(3):293-301.
  98. Sperber AD, Liel Y. Evidence for interference with the intestinal absorption of levothyroxine sodium by aluminum hydroxide. Arch Intern Med. 1992 Jan;152(1):183-4.
  99. Campbell NR, Hasinoff BB, Stalts H, et al. Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism. Ann Intern Med. 1992 Dec 15;117(12):1010-3.
  100. Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000 Jun 7;283(21):2822-5.
  101. Bell DS, Ovalle F. Use of soy protein supplement and resultant need for increased dose of levothyroxine. Endocr Pract. 2001 May-Jun;7(3):193-4.
  102. Lilja JJ, Laitinen K, Neuvonen PJ. Effects of grapefruit juice on the absorption of levothyroxine. Br J Clin Pharmacol. 2005 Sep;60(3):337-41.
  103. Bolk N, Visser TJ, Nijman J, et al. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med. 2010 Dec 13;170(22):1996-2003.
  104. Delange F. Iodine deficiency in Europe and its consequences: an update. Eur J Nucl Med Mol Imaging. 2002 Aug;29 Suppl 2:S404-16.
  105. de Benoist B, McLean E, Andersson M, Rogers L. Iodine deficiency in 2007: global progress since 2003. Food Nutr Bull. 2008;29(3):195-202.
  106. Morton Salt. Available at: Accessed March 17, 2011.
  107. Sidibé el H. [Reflections on mental retardation and congenital hypothyroidism: effects of trace mineral deficiencies]. Sante. 2007 Jan-Mar;17(1):41-50.
  108. Delange F. The disorders induced by iodine deficiency. Thyroid. 1994 Spring;4(1):107-28.
  109. de Escobar GM, Obregón MJ, del Rey FE. Iodine deficiency and brain development in the first half of pregnancy. Public Health Nutr. 2007 Dec;10(12A):1554-70.
  110. Smallridge RC, Ladenson PW. Hypothyroidism in pregnancy: consequences to neonatal health. J Clin Endocrinol Metab. 2001 Jun;86(6):2349-53.
  111. Santiago-Fernandez P, Torres-Barahona R, Muela-Martínez JA, Rojo-Martínez G, García-Fuentes E, Garriga MJ, et al. Intelligence quotient and iodine intake: a cross-sectional study in children. J Clin Endocrinol Metab. 2004 Aug;89(8):3851-3857
  112. Verkaik-Kloosterman J, van 't Veer P, Ocké MC. Reduction of salt: will iodine intake remain adequate in The Netherlands? Br J Nutr. 2010 Dec;104(11):1712-8.
  113. Remer T, Neubert A, Manz F. Increased risk of iodine deficiency with vegetarian nutrition.Br J Nutr. 1999 Jan;81(1):45-9.
  114. Krajcovicová-Kudlácková M, Bucková K, Klimes I, Seboková E. Iodine deficiency in vegetarians and vegans. Ann Nutr Metab. 2003;47(5):183-5.
  115. Laurberg P, Bülow Pedersen I, Knudsen N, Ovesen L, Andersen S. Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid. 2001 May;11(5):457-69.
  116. Duarte GC, Tomimori EK, de Camargo RY, et al. Excessive iodine intake and ultrasonographic thyroid abnormalities in schoolchildren. J Pediatr Endocrinol Metab. 2009 Apr;22(4):327-34.
  117. Leung AM, Braverman LE. Iodine-induced thyroid dysfunction. Curr Opin Endocrinol Diabetes Obes. 2012 Oct;19(5):414-9.
  118. Kohrle J. The trace element selenium and the thyroid gland. Biochimie. 1999 May;81(5):527-33.
  119. Kucharzewski M, Braziewicz J, Majewska U, Góźdź S. Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biol Trace Elem Res. 2002 Jul;88(1):25-30.
  120. Rayman MP. The importance of selenium to human health. Lancet. 2000 Jul 15;356(9225):233-241.
  121. Köhrle J. The trace element selenium and the thyroid gland. Biochimie. 1999 May;81(5):527-33.
  122. Zimmermann MB, Köhrle J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid. 2002 Oct;12(10):867-78.
  123. Sidibé el H. Thyroid diseases in sub-Saharan Africa. Sante.2007 Jan-Mar;17(1):33-9.
  124. Gladyshev VN. Selenoproteins and selenoproteomes. In: Hatfield DL, Berry MJ, Gladyshev VN, eds. Selenium: Its molecular biology and role in human health. 2nd ed. New York: Springer; 2006:99-114.
  125. Mazokopakis EE, Chatzipavlidou V. Hashimoto's thyroiditis and the role of selenium. Current concepts. Hell J Nucl Med. 2007 Jan-Apr;10(1):6-8.
  126. Gärtner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metab. 2002 Apr;87(4):1687-91.
  127. Karanikas G, Schuetz M, Kontur S, et al. No immunological benefit of selenium in consecutive patients with autoimmune thyroiditis. Thyroid. 2008 Jan;18(1):7-12.
  128. Stazi AV, Trinti B. Selenium status and over-expression of interleukin-15 in celiac disease and autoimmune thyroid diseases. Ann Ist Super Sanita. 2010;46(4):389-399.
  129. Gärtner R. Selenium and thyroid hormone axis in critical ill states: an overview of conflicting view points. J Trace Elem Med Biol. 2009;23(2):71-4.
  130. Angstwurm MW, Schopohl J, Gaertner R. Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients. Eur J Endocrinol. 2004 Jul;151(1):47-54.
  131. Hashimoto H, Igarashi N, Yachie A, Miyawaki T, Sato T. The relationship between serum levels of interleukin-6 and thyroid hormone in children with acute respiratory infection. J Clin Endocrinol Metab. 1994 Feb;78(2):288-91.
  132. Kralik A, Eder K, Kirchgessner M. Influence of zinc and selenium deficiency on parameters relating to thyroid hormone metabolism. Horm Metab Res. 1996 May;28(5):223-6.
  133. Nishiyama S, Futagoishi-Suginohara Y, Matsukura M, et al. Zinc supplementation alters thyroid hormone metabolism in disabled patients with zinc deficiency. J Am Coll Nutr. 1994 Feb;13(1):62-7.
  134. Taneja SK, Mandal R. Beneficial effect of modified egg on serum T3, T4 and dyslipidaemia following dietary Zn-supplementation in Wistar rat. Indian J Exp Biol. 2008 Mar;46(3):171-9.
  135. Maret W, Sandstead HH. Zinc requirements and the risks and benefits of zinc supplementation. J Trace Elem Med Biol. 2006;20(1):3-18.
  136. Nations SP, Boyer PJ, Love LA, Burritt MF, Butz JA, Wolfe GI, et al. Denture cream: an unusual source of excess zinc, leading to hypocupremia and neurologic disease. Neurology. 2008 Aug 26;71(9):639-43.
  137. Afrin LB. Fatal copper deficiency from excessive use of zinc-based denture adhesive. Am J Med Sci. 2010 Aug;340(2):164-8.
  138. Duntas LH, Papanastasiou L, Mantzou E, Koutras DA. Incidence of sideropenia and effects of iron repletion treatment in women with subclinical hypothyroidism. Exp Clin Endocrinol Diabetes. 1999;107(6):356-60.
  139. Zimmermann MB, Köhrle J. The impact of iron and selenium deficiencies on iodine and thyroid metabolism: biochemistry and relevance to public health. Thyroid. 2002 Oct;12(10):867-78.
  140. Cinemre H, Bilir C, Gokosmanoglu F, Bahcebasi T. Hematologic effects of levothyroxine in iron-deficient subclinical hypothyroid patients: a randomized, double-blind, controlled study. J Clin Endocrinol Metab. 2009 Jan;94(1):151-6.
  141. Bastian TW, Prohaska JR, Georgieff MK, Anderson GW. Perinatal iron and copper deficiencies alter neonatal rat circulating and brain thyroid hormone concentrations. Endocrinology. 2010 Aug;151(8):4055-65.
  142. Sarandöl E, Taş S, Dirican M, Serdar Z. Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation. Cell Biochem Funct. 2005 Jan-Feb;23(1):1-8.
  143. Oner J, Kükner A, Oner H, Ozan E, Yekeler H. Effect of vitamin E on follicular cell proliferation and expression of apoptosis-associated factors in rats with 6-N-propyl-2-thiouracil-induced goitrogenesis. Folia Histochem Cytobiol. 2003;41(4):213-7.
  144. Goswami R, Marwaha RK, Gupta N, et al. Prevalence of vitamin D deficiency and its relationship with thyroid autoimmunity in Asian Indians: a community-based survey. Br J Nutr. 2009 Aug;102(3):382-6.
  145. Laney N, Meza J, Lyden E, Erickson J, Treude K, Goldner W. The Prevalence of Vitamin D Deficiency Is Similar between Thyroid Nodule and Thyroid Cancer Patients. Int J Endocrinol. 2010;2010:805716.
  146. Jabbar A, Yawar A, Waseem S, et al. Vitamin B12 deficiency common in primary hypothyroidism. J Pak Med Assoc. 2008 May;58(5):258-61.
  147. Morel S, Georges A, Bordenave L, Corcuff JB. Thyroid and gastric autoimmune diseases. Ann Endocrinol (Paris). 2009 Mar;70(1):55-8.
  148. Tagawa N, Tamanaka J, Fujinami A, et al. Serum dehydroepiandrosterone, dehydroepiandrosterone sulfate, and pregnenolone sulfate concentrations in patients with hyperthyroidism and hypothyroidism. Clin Chem. 2000 Apr;46(4):523-8.
  149. Deshpande UR, Joseph LJ, Patwardhan UN, Samuel AM. Effect of antioxidants (vitamin C, E and turmeric extract) on methimazole induced hypothyroidism in rats. Indian J Exp Biol. 2002 Jun;40(6):735-8.
  150. Subudhi U, Das K, Paital B, et al. Supplementation of curcumin and vitamin E enhances oxidative stress, but restores hepatic histoarchitecture in hypothyroid rats. Life Sci. 2009 Mar 13;84(11-12):372-9.
  151. Zubeldia JM, Nabi HA, Del Río MJ, Genovese J. Exploring new applications for Rhodiola rosea: can we improve the quality of life of patients with short-term hypothyroidism induced by hormone withdrawal?J Med Food. 2010 Dec;13(6):1287-92. Epub 2010 Oct 14.
  152. Panossian A, Wikman G. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity. Curr Clin Pharmacol. 2009 Sep;4(3):198-219. Epub 2009 Sep 1.
  153. Panossian A, Wikman G, Kaur P, Asea A. Adaptogens exert a stress-protective effect by modulation of expression of molecular chaperones.Phytomedicine. 2009 Jun;16(6-7):617-22. Epub 2009 Feb 1.
  154. Lakshmy R, Rao PS, Sesikeran B, Suryaprakash P. Lakshmy R, Rao PS, Sesikeran B, Suryaprakash P.Iodine metabolism in response to goitrogen induced altered thyroid status under conditions of moderate and high intake of iodine. Horm Metab Res. 1995 Oct;27(10):450-4.
  155. Fenwick GR, Griffiths NM. The identification of the goitrogen (-)5-vinyloxazolidine-2-thione (goitrin), as a bitter principle of cooked brussels sprouts (Brassica oleracea L. var. gemmifera). Z Lebensm Unters Forsch. 1981 Feb;172(2):90-2.
  156. Osman BA, Ng ML, Bakar AA, Khalid BA. The effect of cassava leave intake on thyroid hormone and urinary iodine.East Afr Med J. 1993 May;70(5):314-5.
  157. Millet--a possibly goitrogenic cereal. Nutr Rev. 1983 Apr;41(4):113-6.
  158. Greer MA Goitrogenic Substances in Food. Am J Clin Nutr. 1957Jul-Aug;5(4): 440-444.
  159. Divi RL, Doerge DR. Inhibition of thyroid peroxidase by dietary flavonoids. Chem Res Toxicol. 1996 Jan-Feb;9(1):16-23.
  160. Divi RL, Chang HC, Doerge DR. Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem Pharmacol. 1997 Nov 15;54(10):1087-96.
  161. Doerge DR, Sheehan DM. Goitrogenic and estrogenic activity of soy isoflavones. Environ Health Perspect. 2002 Jun;110 Suppl 3:349-53.
  162. Chang HC, Doerge DR. Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol Appl Pharmacol. 2000 Nov 1;168(3):244-52.
  163. Dillingham BL, McVeigh BL, Lampe JW, Duncan AM. Soy protein isolates of varied isoflavone content do not influence serum thyroid hormones in healthy young men. Thyroid. 2007 Feb;17(2):131-7.
  164. Senthil K, Jayakodi M, Thirugnanasambantham P, Lee SC, Duraisamy P, Purushotham PM, . . . Yang TJ. Transcriptome analysis reveals in vitro cultured Withania somnifera leaf and root tissues as a promising source for targeted withanolide biosynthesis. BMC genomics. 2015;16(1):14.
  165. Gannon JM, Forrest PE, Roy Chengappa KN. Subtle changes in thyroid indices during a placebo-controlled study of an extract of Withania somnifera in persons with bipolar disorder. Journal of Ayurveda and integrative medicine. Oct-Dec 2014;5(4):241-245.
  166. Ven Murthy MR, Ranjekar PK, Ramassamy C, Deshpande M. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha. Cent Nerv Syst Agents Med Chem. Sep 1 2010;10(3):238-246.
  167. Gajbhiye NA, Makasana J, Kumar S. Accumulation of three important bioactive compounds in different plant parts of Withania somnifera and its determination by the LC-ESI-MS-MS (MRM) method. Journal of chromatographic science. Nov-Dec 2015;53(10):1749-1756.
  168. Raju S. Withania womnifera (Ashwagandha): Analytical Method Development. Accessed 7/28/2016.
  169. Panda S, Kar A. Changes in thyroid hormone concentrations after administration of ashwagandha root extract to adult male mice. The Journal of pharmacy and pharmacology. Sep 1998;50(9):1065-1068.
  170. Kim HG, Cho JH, Yoo SR, et al. Antifatigue effects of Panax ginseng C.A. Meyer: a randomised, double-blind, placebo-controlled trial. PloS One. 2013;8(4):e61271.
  171. Kiefer D, Pantuso T. Panax ginseng. American family physician. Oct 15 2003;68(8):1539-1542.
  172. Shergis JL, Di YM, Zhang AL, Vlahos R, Helliwell R, Ye JM, Xue CC. Therapeutic potential of Panax ginseng and ginsenosides in the treatment of chronic obstructive pulmonary disease. Complementary therapies in medicine. Oct 2014;22(5):944-953.
  173. Shergis JL, Zhang AL, Zhou W, Xue CC. Panax ginseng in randomised controlled trials: a systematic review. Phytotherapy research : PTR. Jul 2013;27(7):949-965.
  174. Shin BK, Kwon SW, Park JH. Chemical diversity of ginseng saponins from Panax ginseng. Journal of Ginseng Research. 2015;39(4):287-298.
  175. Dai X, Zhou Y, Yu X. [Effect of ginseng injection in treating congestive heart failure and its influence on thyroid hormones]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine / Zhongguo Zhong xi yi jie he xue hui, Zhongguo Zhong yi yan jiu yuan zhu ban. Apr 1999;19(4):209-211.
  176. Park KS, Park KI, Kim JW, et al. Efficacy and safety of Korean red ginseng for cold hypersensitivity in the hands and feet: a randomized, double-blind, placebo-controlled trial. Journal of ethnopharmacology. Dec 2 2014;158 Pt A:25-32.
  177. Jin H, Seo JH, Uhm YK, Jung CY, Lee SK, Yim SV. Pharmacokinetic comparison of ginsenoside metabolite IH-901 from fermented and non-fermented ginseng in healthy Korean volunteers. Journal of ethnopharmacology. Jan 31 2012;139(2):664-667.
  178. Leung KW, Wong AS-T. Pharmacology of ginsenosides: a literature review. Chinese medicine. 2010;5(1):1-7.
  179. ILHWA. GinST15 – A Breakthrough in Ginseng Science. Copyright 2015. Accessed 7/28/2016.
  180. RFI. GS15-4 Enzyme-Fermented Ginseng. Copyright 2016. Accessed 7/28/2016.
  181. Shishodia S, Harikumar KB, Dass S, Ramawat KG, Aggarwal BB. The guggul for chronic diseases: ancient medicine, modern targets. Anticancer Res. Nov-Dec 2008;28(6A):3647-3664.
  182. Szapary PO, Wolfe ML, Bloedon LT, et al. Guggulipid for the treatment of hypercholesterolemia: A randomized controlled trial. JAMA. 2003;290(6):765-772.
  183. Shen T, Li GH, Wang XN, Lou HX. The genus Commiphora: A review of its traditional uses, phytochemistry and pharmacology. Journal of ethnopharmacology. 2012;142(2):319-330.
  184. Singh AK, Prasad GC, Tripathi SN. In vitro studies on thyrogenic effect of commiphora mukul (guggulu). Ancient science of life. Jul 1982;2(1):23-28.
  185. Tripathi YB, Malhotra OP, Tripathi SN. Thyroid Stimulating Action of Z-Guggulsterone Obtained from Commiphora mukul. Planta medica. Feb 1984;50(1):78-80.
  186. Panda S, Kar A. Guggulu (Commiphora mukul) potentially ameliorates hypothyroidism in female mice. Phytotherapy research: PTR. Jan 2005;19(1):78-80.
  187. Panda S, Kar A. Gugulu (Commiphora mukul) induces triiodothyronine production: possible involvement of lipid peroxidation. Life sciences. 1999;65(12):PL137-141.
  188. Ross C. Vitamin A. In: Encyclopedia of Dietary Supplements. London and New York: Informa Healthcare; 2010.
  189. Zimmermann MB. Interactions of vitamin A and iodine deficiencies: effects on the pituitary-thyroid axis. International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition. 2007;77(3):236-240.
  190. Higdon J. Linus Pauling Institute: Micronutrient Information Center. Vitamin A. Last updated 1/2015. Accessed 7/28/2016.
  191. Strum JM. Alterations within the rat thyroid gland during vitamin A deficiency. The American journal of anatomy. 1979;156(2):169-182.
  192. Morley JE, Damassa DA, Gordon J, Eugene Pekary A, Hershman JM. Thyroid function and vitamin A deficiency. Life sciences. 1978;22(21):1901-1905.
  193. Aktuna D, Buchinger W, Langsteger W, Meister E, Sternad H, Lorenz O, Eber O. [Beta-carotene, vitamin A and carrier proteins in thyroid diseases]. Acta medica Austriaca. 1993;20(1-2):17-20.
  194. Farhangi MA, Keshavarz SA, Eshraghian M, Ostadrahimi A, Saboor-Yaraghi AA. The effect of vitamin A supplementation on thyroid function in premenopausal women. Journal of the American College of Nutrition. 2012;31(4):268-274.